People

Claude View

People & Governance

Grade: B. A three-decade, promoter-led exporter with genuine skin-in-the-game (MD holds ~30% direct, promoter group 41.34%, zero pledge) and a credentialed 75%-independent board — but with thin bench depth (two executive directors total), a FY25 NSE/BSE monetary penalty for an NRC composition lapse, a Rs. 7.89 Cr MD pay-package on standalone PAT of ~Rs. 56 Cr, and a multi-year pattern of Chirag Parekh over-promising the "Rs. 1,000 Cr FY25" revenue target that the company ultimately missed.

The People Running This Company

Carysil is structurally a one-principal company. Chirag Parekh has been on the board since November 2002 and chairs or sits on every board committee. The only other executive on the board is the CFO (appointed ED in February 2024). The board otherwise is six independent directors, all appointed in the last ~10 years — three of them within the last 24 months, giving the refresh an unusually new feel for a 38-year-old promoter company.

No Results

What matters here: The combination of (a) the MD holding a meaningful personal stake but (b) no other director holding any equity at all is classic promoter-led India. Independent directors are formally independent (SEBI checks pass), but they have no alignment through ownership — only sitting fees of Rs. 5.7 to 7.0 lakhs a year. Dr. Sonal Ambani's term expires March 31, 2026 after two 5-year terms; her replacement will be an early test of whether the board becomes more or less independent.

What They Get Paid

The promoter MD takes a large absolute package relative to the company's profit pool. Shareholders had to approve payment "in excess of threshold limits" as a special resolution (FY23 AGM) — this is the LODR Schedule V trigger, meaning MD compensation exceeded 5% of standalone net profit.

No Results

MD compensation of Rs. 7.89 Cr is ~10x the CFO's package and ~125x the average independent director's sitting fees. Against standalone PAT of roughly Rs. 56 Cr for FY25, this works out to ~14% of standalone profit going to one person — on the high end for an India-listed small-cap and a reason the LODR special-resolution threshold was tripped. On a consolidated basis (PAT ~Rs. 90 Cr) the ratio is softer at ~8.7%, still above median for the peer set.

The commission component is formula-linked (Rs. 86.3 L on FY25 profit), so pay scales with results — the right structural design. But the base+perks block (Rs. 7.03 Cr fixed) is high for a company whose PAT has compounded in the low single-digits over FY24-FY25 despite the revenue narrative. The CFO's compensation was revised upward via postal ballot in March 2025; approval rate was 99.76%, reflecting the minority shareholders' effective powerlessness given the ~41% promoter block.

Are They Aligned?

Ownership and control

The promoter stake has drifted from 44.04% (FY22) to 41.34% (current) — about a 270 bps decline. The step-down in Q2 FY25 (from 43.8% to 41.37%) coincided with the Rs. 125 Cr QIP in July 2024, which diluted the promoter. Importantly, no sales by the promoter themselves — the decline is 100% dilution from fresh issue, not an exit. Zero pledged shares throughout the history is a clean signal.

Insider activity

Insider transaction dataset is empty — no reportable insider purchases or sales filed. Promoter holding held flat at 41.37% for four straight quarters (Dec 2024 to Jun 2025), then 41.34% since. The message is "we raised QIP to grow, not to cash out."

Dilution and capital allocation

No Results

The cleaner takeaway: Chirag Parekh did not chase glossy M&A with QIP funds. The UK acquisitions predated the QIP and are the one blemish — three consolidated UK subsidiaries turned loss-making in FY24/FY25 and required management time. United Granite is the bigger swing: acquired October 2023, integration drags admitted in Q3 FY24 and Q4 FY24 calls, narrative now (Q2 FY26) is a turnaround. Investors are effectively being asked to trust the founder's judgment here — there is no independent acquisition committee disclosed.

The Corporate Governance Report states all RPTs were "in the ordinary course of business and on an arm's length basis" and "not materially significant." There is no explicit disclosure of a promoter-family member on payroll in the data available to this analyst. Audit Committee is 100% independent-member controlled on RPT votes (by SEBI design). No loans/advances to firms-where-directors-are-interested reported for FY25.

Skin-in-the-game score

Skin-in-the-Game Score (out of 10)

6.5

Score: 6.5/10. Scoring rationale: (+) founder-promoter MD with Rs. ~780 Cr of personal stock at risk, (+) zero pledge, (+) 23+ year continuous control, (+) QIP deployed for operating capacity not self-enrichment. (−) No independent directors own any shares — no insider alignment beyond the family, (−) MD comp absorbed 14% of standalone PAT FY25, (−) promoter stake has declined ~270 bps in 4 years (dilution, not selling, but still), (−) family-dominant governance means challenge is structurally weak. Net: more aligned than the average BSE SmallCap but short of best-in-class.

Board Quality

No Results

Independence ratio: 75% (6 of 8) — high for an Indian promoter-led small-cap. Attendance: strong — every director attended at least 7 of 8 board meetings; Parekh, Sharma, Ambani and Godiawala attended all 8. Every director attended the last AGM.

Expertise gaps. The board has finance (three directors), design/R&D (one), legal (one), and sustainability (one). What's missing for a company executing a US export + UK fabrication + domestic retail strategy: no director with US-market or building-products distribution experience; no director with deep M&A/integration experience (Godiawala has insolvency, not corporate M&A); no professional CEO-class operator independent of the promoter family. Katja Larsen's "sustainability" expertise covers ESG check-the-box but she serves on zero other listed boards and has no public corporate track record disclosed.

Committee quality. Audit Committee is chaired by Prabhakar Dalal (independent, finance), Nomination & Remuneration likewise. Risk Management Committee is chaired by Chirag Parekh himself — a structural weakness, as the CEO is marking his own homework on risk. CSR is also MD-chaired, which is acceptable.

**Compliance flag (FY25 penalty).** NSE and BSE each levied monetary penalties on Carysil for non-compliance with Regulation 19(1) of SEBI LODR — the **composition of the Nomination & Remuneration Committee**. Company calls it "inadvertent and unintentional" and reconstituted the NRC on August 8, 2024. For a company whose entire corporate governance section leads with "we comply with all mandatory requirements," a basic NRC-composition failure is unforced and embarrassing. The company paid the fine and moved on; the statutory auditor's Corporate Governance Certificate carries a qualifying note on this exact item.

Promise-vs-delivery record from transcripts. Across 10 consecutive earnings calls, the Chairman consistently anchored guidance and has a mixed delivery record on the two commitments that matter most: the Rs. 1,000 Cr FY25 revenue target, and the 18–20% EBITDA margin band.

No Results

The pattern is: Chirag Parekh over-promised in FY24, course-corrected verbally through FY25 without formally retracting, and has guided FY26 more conservatively (18–20% margin band, which he is now hitting). The IKEA global RFQ win is the first genuinely quantified external validation — if it plays out at 3x the previous share and capacity utilization holds at 85–90%, the FY27 numbers will vindicate the capex. If capacity can't be built fast enough (management has already flagged mold bottlenecks), the narrative softens again.

The Verdict

Overall Governance Grade

Grade: B. Reasonable for an Indian promoter-led exporter — not best-in-class.

Strongest positives.

Founder with Rs. ~780 Cr personal stake, zero pledge, and a 38-year operating history. The most important alignment question — does the person running this company personally care about the stock? — answers a clear yes.
75% independent board with visible refresh (three new IDs in FY24–FY25), real attendance (≥7/8 for all), and committee leadership concentrated with a finance-credentialed Lead Independent Director.
Capital allocation has been operational, not promotional: QIP deployed on capacity tied to a secured IKEA RFQ, no related-party self-dealing disclosed, zero loans/advances to director-connected firms, ESOP pool capped at 3 lakh options.

Real concerns.

MD compensation at ~14% of standalone PAT (required a LODR Schedule V special resolution) is toward the aggressive end, and base-plus-perks of Rs. 7.03 Cr is fixed regardless of performance.
The Risk Management Committee is chaired by the MD himself — the person most exposed to a negative risk finding.
The FY25 NRC-composition LODR violation is a small but telling compliance miss for a company that markets its governance.
Bench depth is thin: if something happened to Chirag Parekh, the only executive on the board is the CFO. No COO, no President, no declared succession plan in the Corporate Governance Report.
Senior-most Independent Director (Sonal Ambani) exits March 31, 2026; who replaces her determines whether the board gets stronger or weaker.

What would cause an upgrade to A–. A formally disclosed succession plan naming an internal #2 beyond the CFO; moving Risk Committee chair to an independent director; a clean FY26 without further SEBI LODR penalties; IKEA ramp delivering the Rs. 1,000 Cr+ milestone that has been promised since FY24.

What would cause a downgrade to C+. Another LODR penalty or related-party disclosure; MD compensation rising again while PAT growth stalls; or an impairment on the UK subsidiaries / United Granite that signals the M&A decisions were not disciplined.